Patent · US Active

Development of HBV-and/or HDV-susceptible cells, cell lines and non-human animals

US10618947B2 · kind B2 · utility

0Cited by

1References

4Claims

0Family size

Assignee

RUPRECHT - KARLS - UNIVERSITÄT HEIDELBERG · DE

Inventors

Stephan Urban · Neustadt, DE
Yi Ni · Heidelberg, DE

Key dates

Filing date	Nov 12, 2013
Grant date	Apr 14, 2020
Priority date	—
Expiry date	Nov 12, 2033

Classification

Technology area (CPC G)Physics
CPC primaryG01N2500/02
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

The present invention relates to a novel Hepatitis B virus (HBV) and/or Hepatitis D virus (HDV) receptor and its use for the development of cells, cell lines and non-human animals that are susceptible to HBV and/or HDV infection and can be used for immunological studies and/or for the screening of drugs, post-entry restriction factors and host dependency factors. It further relates to the use of the receptor for the identification of compounds useful in the treatment of HBV and/or HDV infection.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.